Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Radiofrequency Ablation for Indeterminate Bethesda III Thyroid Nodules

NCT05189808 is registered in ClinicalTrials.gov with Columbia University as lead sponsor.

NCT NCT05189808
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05189808 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Radiofrequency Ablation for Indeterminate Bethesda III Thyroid Nodules
Lead sponsor
Columbia University
Phase
Observational
Overall status
Recruiting
Start date
August 1, 2020
Completion date
August 31, 2028
Enrollment
50 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

indeterminate bethesda iii thyroid nodules